ADIPOQ and obesity disorder: Preclinical and clinical studies implicate chronic low-grade inflammation in the pathophysiology of obesity, evidenced by increased circulating levels of proinflammatory cytokines, acute-phase proteins such as C-reactive protein (CRP) and altered levels of adipokines (such as adiponectin and leptin) 10.